Preparation and photocatalytic performance of UIO-66/La-MOF composite.

To improve the photocatalytic degradation efficiency of photocatalytic materials UIO-66 and La-MOFs under visible-light irradiation, a series of photocatalytic materials with La and Zr as metal centers and terephthalic acid (H2BDC) and 2-amino terephthalic acid (H2ATA) as organic ligands were prepared by solvothermal method. The photocatalytic materials were characterized by X-ray diffraction (XRD), scanning electron microscopy (SEM), UV-visible (UV-vis) spectroscopy, Fourier transform infrared (FT-IR) spectroscopy, and Mott-Schottky test. The photocatalytic degradation performance to Rhodamine B of the catalysts was fully investigated. Results show that the H2ATA series had stronger visible-light absorption capacity and better photocatalytic performance. The 0.35 La/Zr-H2ATA composite showed the best photocatalytic degradation. The quenching experiments confirmed that the active species in the photocatalytic degradation were the holes and superoxide radicals. The possible mechanisms of the carrier migration paths in the energy level matching for La/Zr-H2BDC and La/Zr-H2ATA were also discussed in detail.

The study of honokiol as a natural product-based antimicrobial agent and its potential interaction with FtsZ protein.

Multidrug resistant bacteria have been a global health threat currently and frontline clinical treatments for these infections are very limited. To develop potent antibacterial agents with new bactericidal mechanisms is thus needed urgently to address this critical antibiotic resistance challenge. Natural products are a treasure of small molecules with high bioactive and low toxicity. In the present study, we demonstrated that a natural compound, honokiol, showed potent antibacterial activity against a number of Gram-positive bacteria including MRSA and VRE. Moreover, honokiol in combination with clinically used ß-lactam antibiotics exhibits strong synergistic antimicrobial effects against drug-resistant S. aureus strains. Biochemical studies further reveal that honokiol may disrupt the GTPase activity, FtsZ polymerization, cell division. These biological impacts induced by honokiol may ultimately cause bacterial cell death. The in vivo antibacterial activity of honokiol against S. aureus infection was also verified with a biological model of G. mellonella larvae. The in vivo results support that honokiol is low toxic against the larvae and effectively increases the survival rate of the larvae infected with S. aureus. These findings demonstrate the potential of honokiol for further structural advancement as a new class of antibacterial agents with high potency against multidrug-resistant bacteria.